ProCE Banner Activity

Key Viral Hepatitis Studies Influencing My Practice Following AASLD 2021

Podcast Episodes
Conference Coverage
Listen to expert insights from Nancy Reau, MD, on updates and new viral hepatitis data from AASLD 2021, including HBV treatment in pregnancy, outcomes following HBV treatment withdrawal, progress toward HBV cure, HCV implementation science and the cascade of care, characterization of the population with hepatitis delta, and phase III clinical trial updates for hepatitis delta.

Released: December 01, 2021

Expiration: November 30, 2022

Share

Faculty

Nancy Reau

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Nancy Reau, MD, has disclosed that she has received funds for research support paid to her institution from AbbVie and Gilead Sciences and consulting fees from AbbVie, Arbutus, Gilead Sciences, Intercept, and Salix.